|
" Mouse models for drug discovery : "
edited by Gabriele Proetzel and Michael V. Wiles.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
969864
|
| Doc. No
|
:
|
b724234
|
| Title & Author
|
:
|
Mouse models for drug discovery : : methods and protocols /\ edited by Gabriele Proetzel and Michael V. Wiles.
|
| Publication Statement
|
:
|
Totowa, N.J. :: Humana,, ©2010.
|
| Series Statement
|
:
|
Methods in molecular biology,; 602
|
|
|
:
|
Springer protocols
|
| Page. NO
|
:
|
1 online resource (xii, 421 pages) :: illustrations
|
| ISBN
|
:
|
1607610582
|
|
|
:
|
: 9781607610588
|
|
|
:
|
1607610574
|
|
|
:
|
9781607610571
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Improving toxicity screening and drug development by using genetically defined strains / Michael F.W. Festing -- Sophisticated mouse: protecting a precious reagent / Michael V. Wiles, Rob A. Taft -- Genetically engineered mouse models in drug discovery research / Rosalba Sacca, Sandra J. Engle, Wenning Qin, Jeffrey L. Stock, John D. McNeish -- Engineering the mouse genome to model human disease for drug discovery / Frank Koentgen, Gabriele Suess, Dieter Naf -- Profiling of drug action using reporter mice and molecular imaging / Gianpaolo Rando, Andrea Biserni, Paolo Ciana, Adriana Maggi -- Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies / Derry C. Roopenian, Gregory J. Christianson, Thomas J. Sproule -- Development of novel major histocompatibility complex class I and class II-defecient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease / Steve Pino, Michael A. Brehm, Laurence Covassin-Barberis, Marie King, Bruce Gott, Thomas H. Chase, Jennifer Wagner, Lisa Burzenski, Oded Foreman, Dale L. Greiner, Leonard D. Shultz -- Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type I diabetes in humans / David V. Serreze, Marijke Niens, John Kulik, Teresa P. DeLorenzo -- Mouse models of type II diabetes mellitus in drug discovery / Helene Baribault -- Cholesterol absorption and metabolism / Philip N. Howles -- Collegen-induced arthritis in mice / Lisette Bevaart, Margriet J. Vervoordeldonk, Paul P. Tak -- Skin diseases in laboratory mice: approaches to drug tartget identification and efficacy screening / John P. Sundbert, Kathleen A. Sliva, Caroline McPhee, Lloyd E. King -- Models of metastasis in drug discovery / James E. Talmadge -- Methods for evaluating effects of an ironotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging / David Surguladze, Philipp Steiner, Marie Prewetz, James R. Tonra -- CML mouse model in translational research / Cong Peng, Shaoguang Li -- Mouse models for studying depression-like states and antidepressant drugs / Carisa L. Bergner, Amanda N. Smolinsky, Peter C. Hart, Brett D. Dufour, Rupert J. Egan, Justin L. LaPorte, Allan V. Kaleuff -- Virus-delivered RNA interference in mouse brain to study addiction-related behaviors / Amy W. Lasek, Nourredine Azouaou -- Experimental models of anxiety for drug discovery and brain research / Peter C. Hart, Carisa L. Bergner, Amanda N. Smolinsky, Brett D. Dufour, Rupert J. Egan, Justin L. LaPorte, Allan v. Kalueff -- Mouse models of neurodegenerative diseases: criteria and general methodology / Christopher Janus, Hans Welzl -- Neuromuscular disease models and analysis / Robert W. Burgess, Gregory A. Cox, Kevin L. Seburn -- Murine model of cutaneous infection with Streptococcus pyogenes / Eva Medina -- Murine model of pneumococcal pneumonia / Eva Medina -- Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP) / Eva Medina.
|
| Abstract
|
:
|
As the drug discovery process shifts more and more toward specifically targeting pathways and molecules, model systems continue to increase in importance, and the mouse, with its versatility, ease of use, and remarkable similarity to the human genome, has clearly risen to the forefront of animal model studies. In Mouse Models for Drug Discovery: Methods and Protocols, experts in the field present some background for those less familiar with mice as experimental model platforms as well as a collection of techniques involving general methods as well as specific disease topics such as type 1 and 2 diabetes, cardiovascular disease, arthritis, skin disorders, cancer, the use of behavioral models for depression and anxiety, neurodegenerative diseases, neuromuscular diseases, and infectious diseases. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easy-to-use, Mouse Models for Drug Discovery: Methods and Protocols will stimulate those not familiar with the power of the mouse and its potential for the drug discovery process, and it will encourage the development of new models and new ways to utilize existing models in order to further the use of this dynamic animal in this vital field.
|
| Subject
|
:
|
Animal models in research.
|
| Subject
|
:
|
Drug development.
|
| Subject
|
:
|
Drugs-- Physiological effect.
|
| Subject
|
:
|
Mice-- Diseases-- Molecular aspects.
|
| Subject
|
:
|
Mice-- Effect of drugs on.
|
| Subject
|
:
|
Drug Design.
|
| Subject
|
:
|
Drug Evaluation, Preclinical.
|
| Subject
|
:
|
Mice.
|
| Subject
|
:
|
Models, Animal.
|
| Subject
|
:
|
Animal models in research.
|
| Subject
|
:
|
Drug development.
|
| Subject
|
:
|
Drugs-- Physiological effect.
|
| Subject
|
:
|
Health Biological Sciences.
|
| Subject
|
:
|
Pharmacy, Therapeutics, Pharmacology.
|
| Dewey Classification
|
:
|
615.580724
|
| LC Classification
|
:
|
RM301.25
|
| NLM classification
|
:
|
QV 744M932 2010
|
|
|
:
|
W1ME9616J v.602 2010
|
| Added Entry
|
:
|
Proetzel, Gabriele.
|
|
|
:
|
Wiles, Michael V.
|
| |